应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MBRX Moleculin Biotech, Inc.
已收盘 04-19 16:00:00 EDT
4.65
+0.13
+2.80%
盘后
4.65
+0.00
0.00%
16:00 EDT
最高
4.66
最低
4.40
成交量
1.06万
今开
4.59
昨收
4.52
日振幅
5.75%
总市值
1,036万
流通市值
895.27万
总股本
222.75万
成交额
4.79万
换手率
0.55%
流通股本
192.53万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Moleculin Biotech Inc 预计每股亏损 20 美分 - 财报前瞻
Reuters · 03-19
Moleculin Biotech Inc 预计每股亏损 20 美分 - 财报前瞻
Moleculin Biotech, Inc.盘中异动 股价大涨15.25%报0.570美元
自选股智能写手 · 03-18
Moleculin Biotech, Inc.盘中异动 股价大涨15.25%报0.570美元
加载更多
公司概况
公司名称:
Moleculin Biotech, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Moleculin Biotech, Inc.是一家于2015年7月在特拉华州成立的临床药物研制公司,着眼于开发抗癌药物的研发,主要与德克萨斯州大学的M.D. Anderson癌症中心合作。他们的主要研制药品是脂质的安那霉素,用于治疗复发性或急性白血病。除此之外还有两种正在开发的其他药物,一是WP1066药物,主要控制参与癌症的关键转录调控因子;二是WP1122药物,主要通过分子靶来影响癌症细胞的代谢过程。
发行价格:
--
{"stockData":{"symbol":"MBRX","market":"US","secType":"STK","nameCN":"Moleculin Biotech, Inc.","latestPrice":4.65,"timestamp":1713556800000,"preClose":4.5235,"halted":0,"volume":10562,"hourTrading":{"tag":"盘后","latestPrice":4.65,"preClose":4.65,"latestTime":"16:00 EDT","volume":83,"amount":385.95,"timestamp":1713556803473},"delay":0,"floatShares":1925311,"shares":2227516,"eps":-13.484715,"marketStatus":"已收盘","marketStatusCode":5,"change":0.1265,"latestTime":"04-19 16:00:00 EDT","open":4.59,"high":4.66,"low":4.4001,"amount":47905.461366,"amplitude":0.057456,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-13.484715,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1713772800000},"adr":0,"adjPreClose":4.5235,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":4.58,"preClose":4.54,"latestTime":"08:39 EDT","volume":8,"amount":36.46,"timestamp":1713530398006},"postHourTrading":{"tag":"盘后","latestPrice":4.65,"preClose":4.65,"latestTime":"16:00 EDT","volume":83,"amount":385.95,"timestamp":1713556803473},"volumeRatio":0.460812},"requestUrl":"/m/hq/s/MBRX","defaultTab":"news","newsList":[{"id":"2420280854","title":"Moleculin Biotech Inc 预计每股亏损 20 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2420280854","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2420280854?lang=zh_cn&edition=full","pubTime":"2024-03-19 04:22","pubTimestamp":1710793331,"startTime":"0","endTime":"0","summary":" * Moleculin Biotech Inc 预计在3月20日发布业绩报告时,季度营收将保持不变() 预计截至2023年12月31日的业绩将保持不变。* * LSEG 的分析师平均预计 Moleculin Biotech Inc 每股亏损 20 美分。* 华尔街对 Moleculin Biotech Inc 的 12 个月目标价中位数为 3.00 美元,高于上一次 0.49 美元的收盘价。3月18日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2420474150","title":"Moleculin Biotech, Inc.盘中异动 股价大涨15.25%报0.570美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420474150","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420474150?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:34","pubTimestamp":1710768847,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时34分,Moleculin Biotech, Inc.股票出现波动,股价急速上涨15.25%。截至发稿,该股报0.570美元/股,成交量8810股,换手率0.03%,振幅4.02%。Moleculin Biotech, Inc.股票所在的生物技术行业中,整体跌幅为0.14%。Moleculin Biotech, Inc.公司简介:Moleculin Biotech Inc是一家临床阶段的制药公司,专注于通过开发其候选药物来治疗高度耐药的癌症和病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403182134078b434edc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403182134078b434edc&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.moleculin.com","stockEarnings":[{"period":"1week","weight":-0.0517},{"period":"1month","weight":-0.4243},{"period":"3month","weight":-0.4486},{"period":"6month","weight":-0.4889},{"period":"1year","weight":-0.623},{"period":"ytd","weight":-0.6487}],"compareEarnings":[{"period":"1week","weight":-0.0357},{"period":"1month","weight":-0.0314},{"period":"3month","weight":0.0354},{"period":"6month","weight":0.186},{"period":"1year","weight":0.2062},{"period":"ytd","weight":0.0509}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Moleculin Biotech, Inc.是一家于2015年7月在特拉华州成立的临床药物研制公司,着眼于开发抗癌药物的研发,主要与德克萨斯州大学的M.D. Anderson癌症中心合作。他们的主要研制药品是脂质的安那霉素,用于治疗复发性或急性白血病。除此之外还有两种正在开发的其他药物,一是WP1066药物,主要控制参与癌症的关键转录调控因子;二是WP1122药物,主要通过分子靶来影响癌症细胞的代谢过程。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.042816},{"month":2,"riseRate":0.25,"avgChangeRate":-0.069703},{"month":3,"riseRate":0.25,"avgChangeRate":-0.110793},{"month":4,"riseRate":0.375,"avgChangeRate":0.067625},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.063177},{"month":6,"riseRate":0.285714,"avgChangeRate":0.179766},{"month":7,"riseRate":0.625,"avgChangeRate":0.096418},{"month":8,"riseRate":0.25,"avgChangeRate":-0.088841},{"month":9,"riseRate":0,"avgChangeRate":-0.104695},{"month":10,"riseRate":0.125,"avgChangeRate":-0.150211},{"month":11,"riseRate":0.5,"avgChangeRate":0.055295},{"month":12,"riseRate":0.375,"avgChangeRate":-0.024821}],"exchange":"NASDAQ","name":"Moleculin Biotech, Inc.","nameEN":"Moleculin Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Moleculin Biotech, Inc.(MBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Moleculin Biotech, Inc.(MBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Moleculin Biotech, Inc.,MBRX,Moleculin Biotech, Inc.股票,Moleculin Biotech, Inc.股票老虎,Moleculin Biotech, Inc.股票老虎国际,Moleculin Biotech, Inc.行情,Moleculin Biotech, Inc.股票行情,Moleculin Biotech, Inc.股价,Moleculin Biotech, Inc.股市,Moleculin Biotech, Inc.股票价格,Moleculin Biotech, Inc.股票交易,Moleculin Biotech, Inc.股票购买,Moleculin Biotech, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Moleculin Biotech, Inc.(MBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Moleculin Biotech, Inc.(MBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}